The current valuation score of Regenxbio Inc is 6.76, ranking 292 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.72, which is -41.27% below the recent high of -1.01 and -168.56% above the recent low of -4.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.